Juul and Altria settlement payments begin as some users confirm payments received

Oct.25.2024
Juul and Altria settlement payments begin as some users confirm payments received
Juul Labs has begun issuing settlement payments following its agreement with Altria, with a total payout of $300 million. Users have reported on social media that they've received amounts ranging from a few hundred dollars to over $9,000.

The 2022 settlement agreement between e-cigarette company Juul and tobacco company Altria has begun to be paid out, with users on platforms such as Reddit and X claiming to have already received thousands of dollars in compensation, according to a 22 October report from Forbes.

 

The settlement amount for this case is $3 billion, to be paid jointly by Juul and Altria. The lawsuit alleged that consumers paid inflated prices for e-cigarettes, that Juul failed to accurately disclose the addictive and safety risks of its products, and that it engaged in illegal marketing to minors.

 

The payouts were approved earlier this month, according to the r/juul subreddit. Users have reported receiving amounts ranging from a few hundred dollars to over $9,000. Some X users have shared screenshots of their payments, while others are disappointed that they were not included in the settlement list. The settlement agreement includes consumers who purchased Juul products before 7 December 2022. Juul did not admit any wrongdoing in the settlement, and Altria has denied the allegations against it.

 

Juul and Altria settlement payments begin as some users confirm payments received
Some users of platform X claim to have received compensation | Image source: X

 

 

Juul and Altria settlement payments begin as some users confirm payments received
Some X platform users claimed to have received compensation | Image source: X

 

The amount of compensation is influenced by several factors, including the amount the claimant spent on Juul products, the time period of the purchase, and the age at the time of the purchase. Obviously, users who spent more during the qualifying period will receive more compensation.

 

The class action stems from more than 8,000 lawsuits filed against Juul by municipalities, school districts, indigenous tribes and individuals. In 2019, Juul stopped advertising in the US market and discontinued most of its flavoured products due to legal disputes and government sanctions.

 

Following a multi-state investigation into its marketing practices, the company reached a settlement agreement for nearly $4.4 billion, followed by another agreement for $3 billion. In 2018, Altria had invested nearly $13 billion in Juul, but pulled out of the investment last year and invested in another competing startup. Juul avoided bankruptcy through cost-cutting, massive layoffs and support from wealthy investors.
 

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Research Summary | NHANES Study: Smoking or E-Cigarette Use Linked to Higher Prevalence of Elevated Blood Pressure and Hypertension
Research Summary | NHANES Study: Smoking or E-Cigarette Use Linked to Higher Prevalence of Elevated Blood Pressure and Hypertension
A cross-sectional analysis based on the US NHANES 2021–2023 cycle, including 6,262 participants aged over 12, found that compared with people who neither smoke nor vape, those who smoke and/or use e-cigarettes had a higher prevalence of elevated blood pressure and hypertension. After full adjustment, smoking/vaping was associated with elevated blood pressure (aOR 1.34) and hypertension (aOR 1.46), and with a 1.05 mmHg higher diastolic blood pressure.
Feb.09 by 2FIRSTS.ai
Kansas Senate approves tougher vape rules to target unlicensed products and child-directed ads
Kansas Senate approves tougher vape rules to target unlicensed products and child-directed ads
The Kansas Senate approved Senate Bill 355 on Wednesday, aiming to crack down on unlicensed vaping products and eliminate advertisements geared toward children. The bill, backed by major tobacco companies, would impose the same licensing and advertising requirements on e-cigarettes as other nicotine products and require every e-cigarette manufacturer doing business in Kansas to obtain a license, with a $2,500 application fee.
Feb.13 by 2FIRSTS.ai
Make Your Brand Understood by the People Who Matter
Make Your Brand Understood by the People Who Matter
Feb.02
Product | 22ml Combined E-Liquid Supply, Rated for 35,000 Puffs: OXBAR Launches the OX35K Open-System Pod Device
Product | 22ml Combined E-Liquid Supply, Rated for 35,000 Puffs: OXBAR Launches the OX35K Open-System Pod Device
The vaping brand OXBAR has recently listed its open-system, refillable pod device OX35K on its official website. The product features a “2ml built-in pod + two 10ml external refill bottles” e-liquid supply structure and supports top refilling, with a claimed puff count of up to 35,000. It is equipped with a 1000mAh built-in battery and offers dual power modes—BOOST and ECO—positioning the device to balance high-puff performance with an open-system form factor.
Jan.13 by 2FIRSTS.ai
2Firsts “Decisive 2026” Concludes: Reviewing the 2025 U.S. Market and Mapping Compliance Pathways Ahead
2Firsts “Decisive 2026” Concludes: Reviewing the 2025 U.S. Market and Mapping Compliance Pathways Ahead
2Firsts hosted “Decisive 2026” in Shenzhen, bringing together industry perspectives to examine major shifts in the U.S. new tobacco market in 2025 and their global implications. Sessions covered U.S. market dynamics, technical insights from recently PMTA-authorized products, an investor lens on tobacco capital markets, and 2025 news/product highlights. The event underscored a structural shift from “gray business” toward compliance and sustainable growth, expected to become clearer by 2026.
Jan.09
PMI Launches Mass Production of ZYN at $600M Aurora Manufacturing Hub
PMI Launches Mass Production of ZYN at $600M Aurora Manufacturing Hub
Philip Morris International (PMI), through its subsidiary Swedish Match, has started large-scale production at a 600,000-square-foot ZYN nicotine pouch facility in Aurora, Colorado. The $600 million investment makes the site one of three ZYN manufacturing plants in the United States and the company’s second U.S. facility after Owensboro, Kentucky.
PMI
Feb.21